Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-12-016761
Filing Date
2012-12-03
Accepted
2012-12-03 16:50:31
Documents
1
Period of Report
2012-11-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3064
  Complete submission text file 0001179110-12-016761.txt   4196
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Issuer) CIK: 0001157601 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations

Mailing Address 157 TECHNOLOGY DRIVE IRVINE CA 92618
Business Address
Singh Amar (Reporting) CIK: 0001486809 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33277 | Film No.: 121237989